Factors determining anti-poliovirus type 3 antibodies among orally immunised Indian infants
详细信息 查看全文
- 作者：Saravanakumar Puthupalayam Kaliappana ; saravanakumar@cmcvellore.ac.in" class="auth_mail" title="E-mail the corresponding author ; Srinivasan Venugopala ; srinistat09@gmail.com" class="auth_mail" title="E-mail the corresponding author ; Sidhartha Giria ; sidharthgiri@cmcvellore.ac.in" class="auth_mail" title="E-mail the corresponding author ; Ira Praharaja ; irapraharaj@cmcvellore.ac.in" class="auth_mail" title="E-mail the corresponding author ; Arun S. Karthikeyana ; arun.karthikeyan@cmcvellore.ac.in" class="auth_mail" title="E-mail the corresponding author ; Sudhir Babjia ; sudhirbabji@cmcvellore.ac.in" class="auth_mail" title="E-mail the corresponding author ; Jacob Johnb ; jacob@cmcsph.org" class="auth_mail" title="E-mail the corresponding author ; Jayaprakash Muliyila ; jpmuliyil@gmail.com" class="auth_mail" title="E-mail the corresponding author ; Nicholas Grasslyc ; n.grassly@imperial.ac.uk" class="auth_mail" title="E-mail the corresponding author ; Gagandeep Kanga ; gkang@cmcvellore.ac.in" class="auth_mail" title="E-mail the corresponding author
- 关键词：tOPV ; trivalent oral polio vaccine ; PV3 ; poliovirus serotype 3 ; WHO ; World Health Organization ; MLR ; multilevel logistic regression ; SD ; standard deviation ; CI ; confidence interval ; OR ; odds ratio ; OPV ; oral poliovirus vaccine ; mOPV3 ; serotype-3 monovalent oral poliovirus vaccine ; IPV ; inactivated poliovirus vaccine ; HSC ; health sub-centre ; PHC ; primary health centre ; SIA ; supplemental immunisation activity ; CDC ; Centers for Disease Control and Prevention ; TCID50 ; median tissue culture infective
- 刊名：Vaccine
- 出版年：2016
- 出版时间：22 September 2016
- 年：2016
- 卷：34
- 期：41
- 页码：4979-4984
- 全文大小：456 K
文摘
- •
88.1% of 8454 children screened had protective antibodies to poliovirus serotype 3.
- •
The number of tOPV doses received was the main determinant of seroprevalence.
- •
Age, gender, residence and number of tOPV doses are associated with seroprevalence.